JADPRO Live 2018 Certified Educational Activities

Earn CE credit with these certified educational activities based on presentations from JADPRO Live at APSHO 2018. Access the full-length video presentation, the slide deck, transcript, and the entire lecture as a podcast. You can earn CE for each of these activities by following the links.

Click on any of the video presentations below to get started!

CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome

Learn from two experts on how to identify patients who meet criteria as candidates for CAR T-cell therapy and apply strategies to mitigate associated serious side effects, including cytokine release syndrome.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Sequencing Therapies in Indolent Lymphomas (FL and CLL)

Discover current best practices for treating follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL), including monitoring patients with CLL for 17p deletion at diagnosis and throughout the course of the disease and current and emerging data supporting combination therapies in CLL and novel targeted therapies for newly diagnosed and relapsed/refractory FL.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Therapeutic Advances in Prostate Cancer

Learn from two experts in the field of prostate cancer as they discuss clinical data of emerging and current agents for the treatment of non-metastatic castration-resistant prostate cancer for rapidly rising prostate-specific antigen levels, the role of docetaxel and abiraterone in newly diagnosed metastatic disease, emerging data on the role of genomics in metastatic castration-sensitive and -resistant disease, and strategies to manage toxicities of current and emerging treatments.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Evolving Strategies to Manage Treatment-Related Adverse Events for Patients with Classical Hodgkin Lymphoma

Discover how to prevent and mitigate adverse events of established and emerging cytotoxic regimens, novel agents, and checkpoint inhibitors used to treat classical Hodgkin lymphoma, including best practices and emerging data.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


New Directions in Myeloid Malignancies

Review strategies to monitor minimal residual disease in myeloid malignancies, as well as the safety and efficacy of novel treatment approaches and associated mutations such as IDH2, TP53, FLT3, BCL2, and cell surface antigen CD33.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Sequencing of Treatments for Patients With Ovarian Cancer

Take a deep dive into the history of ovarian cancer treatment, evaluate current options for first-line and maintenance therapy, and review safety and efficacy data for PARP inhibitors alone and in combination with immunotherapy or anti-angiogenic agents.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


New Drug Updates in Hematologic Malignancies

Discover the latest pharmacology and indication approvals for the management of patients with hematologic malignancies, including pivotal clinical trial data, associated signs and symptoms of serious or life-threatening adverse effects, and the impact of these agents in advanced practice.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Differential Diagnosis and Testing for Hematologic Malignancies

With the backdrop of three unique, real-life case studies, learn how to interpret advancements in diagnostic tests used in risk stratification for hematologic malignancies, including next-generation sequencing for the discovery of novel molecular abnormalities as defined by the World Health Organization and European Leukemia Network.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Advancing the Management of Plasma Cell Dyscrasias

Through expert, case-based discussion, learn how to interpret differential diagnoses of plasma cell dyscrasias, implement the recent changes in the clinical management of the spectrum of multiple myeloma, evaluate the risks and benefits of early treatments for smoldering myeloma, and plan management strategies for patients with solitary plasmacytomas and amyloidosis.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Management of Side Effects for Patients Receiving Multimodality Therapy in Thoracic Oncology

Discover strategies to mitigate adverse events (AEs) of checkpoint inhibitors and radiotherapy for patients with thoracic cancer, and review emerging data regarding managing AEs of EGFR and ALK inhibitors.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


New Drug Updates in Solid Tumors

Review the pharmacology and approved indications of medications for the management of solid tumors, including pivotal clinical trial data, the signs and symptoms of associated serious or life-threatening adverse effects, and each drug’s impact on advanced practice.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Evolving Therapies in the Clinical Management of Melanoma

Take a deep dive into clinical data supporting immunotherapies and emerging targeted therapies for the treatment of advanced/metastatic melanoma, as well as strategies to manage and mitigate associated adverse events.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Preventing and Treating Venous Thrombosis in Oncology

Discover how to interpret recent findings comparing safety and efficacy of “standard” anticoagulants with those of direct oral anticoagulants (DOACs), evaluate the risks and benefits of treatment of DOACs, and monitor and assess patient response to anticoagulant treatment.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


Sequencing Therapies in Renal Cell Carcinoma

Review strategies for how to best utilize immunotherapy in renal cell carcinoma, including tyrosine kinase inhibitors in the adjuvant setting in patients with advanced disease.

Posted: January 31, 2019 / Expires: January 31, 2020

Estimated time to complete: 1 hour

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


JADPRO Live Non-Certified Video


KEYNOTE ADDRESS: Integrating Palliative Care Into the Cancer Care Setting: The Role of the Advanced Practitioner

Review the importance of, and barriers to, integrating palliative care throughout the entire continuum of cancer care, along with supporting data and real-life patient stories, as well as the vital role advanced practitioners play in this evolution of care.

Access the Activity for CE Credit*
   
Watch Video Without Claiming Credit

* This link will take you to the Annenberg
Center for Health Sciences website.


JADPRO Live Non-Certified Video


Mary Pazdur Award

Watch Video Without Claiming Credit


Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.